Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

NURO 1.75 +0.08 (4.79%)
price chart
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
FDA clears NeuroMetrix wearable tech  Boston Globe
NeuroMetrix (NURO) FDA Green Lights Chronic Pain Device, Warren Resources ...  SmallCap Network
Related articles »  
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell´┐Ż, the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015.
Related articles »  
Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
Related articles »  
The Future Of NeuroMetrix
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so.
Related articles »  
Morning Most Volatile: NeuroMetrix Inc. (NURO), Alon Blue Square Israel Ltd ...
NeuroMetrix Inc. (NURO) of the Healthcare sector has gained 3.55% from opening today with a volume of 34,015 shares and volatility of 5.08%.
NeuroMetrix Is Better Positioned After Share Raise
Yesterday morning, NeuroMetrix (NASDAQ:NURO) announced that the company was able to raise more than $10,000,000 by offering 10,500,000 shares at $1 per share, plus warrants.
Related articles »  
NeuroMetrix CEO Dr. Shai N. Gozani Interviewed Live on TuDiabetes.org
WALTHAM, Mass.--(BUSINESS WIRE)--Shai N. Gozani, M.D., Ph.D, President and Chief Executive Officer of NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of ...
Related articles »  
Monday's Hot List: Apple Inc. (AAPL), Morgan Stanley (MS), Amicus ...
Neurometrix Inc (NASDAQ:NURO) I got excited yesterday when I received a tweet from a follower informing me about a press release out of Japan that Omron will start selling the NeuroMetrix device.
NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of The Japan Society of Diabetic ...
Related articles »